Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8176704rdf:typepubmed:Citationlld:pubmed
pubmed-article:8176704lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0010097lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0162512lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0016733lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0028823lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C1159719lld:lifeskim
pubmed-article:8176704lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:8176704pubmed:issue9lld:pubmed
pubmed-article:8176704pubmed:dateCreated1994-6-9lld:pubmed
pubmed-article:8176704pubmed:abstractTextA novel entry to tropane analogs of cocaine was developed on the basis of the reaction of rhodium-stabilized vinylcarbenoids with pyrroles. These analogs were tested in binding to dopamine and serotonin (5-HT) transporters in membranes from rat striatum and frontal cortex. In all the analogs, the aryl group at the 3-position was directly bound to the tropane ring (as in WIN-35,428), and methyl or ethyl ketone moieties were present at the 2-position instead of the typical ester group. The series of analogs containing a 2-naphthyl group at the 3-position were most potent, with Ki values < 1 nM in binding to both dopamine and 5-HT transporters. Although the unsubstituted 2-naphthyl analog was nonselective at dopamine and 5-HT transport sites, other compounds were selective for either site. In general, compounds with relatively small substituents on the aromatic moiety (such as p-methyl or p-fluoro) were relatively selective for the dopamine transporters, while a p-isopropylphenyl derivative was selective for the 5-HT transport sites. This latter compound represents the first N-methyltropane derivative specific for 5-HT transporters. Resolution of two of the most significant analogs was achieved by HPLC on a chiral stationary phase; the active enantiomer of a 2-naphthyl analog exhibited Ki values of < 0.1 nM at both dopamine and 5-HT transporter sites.lld:pubmed
pubmed-article:8176704pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:languageenglld:pubmed
pubmed-article:8176704pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:citationSubsetIMlld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8176704pubmed:statusMEDLINElld:pubmed
pubmed-article:8176704pubmed:monthAprlld:pubmed
pubmed-article:8176704pubmed:issn0022-2623lld:pubmed
pubmed-article:8176704pubmed:authorpubmed-author:ChildersS RSRlld:pubmed
pubmed-article:8176704pubmed:authorpubmed-author:SextonTTlld:pubmed
pubmed-article:8176704pubmed:authorpubmed-author:HubyN JNJlld:pubmed
pubmed-article:8176704pubmed:authorpubmed-author:DaviesH MHMlld:pubmed
pubmed-article:8176704pubmed:authorpubmed-author:SaikaliEElld:pubmed
pubmed-article:8176704pubmed:authorpubmed-author:GilliattV JVJlld:pubmed
pubmed-article:8176704pubmed:authorpubmed-author:MatasiJ JJJlld:pubmed
pubmed-article:8176704pubmed:issnTypePrintlld:pubmed
pubmed-article:8176704pubmed:day29lld:pubmed
pubmed-article:8176704pubmed:volume37lld:pubmed
pubmed-article:8176704pubmed:ownerNLMlld:pubmed
pubmed-article:8176704pubmed:authorsCompleteYlld:pubmed
pubmed-article:8176704pubmed:pagination1262-8lld:pubmed
pubmed-article:8176704pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:meshHeadingpubmed-meshheading:8176704-...lld:pubmed
pubmed-article:8176704pubmed:year1994lld:pubmed
pubmed-article:8176704pubmed:articleTitleSynthesis of 2 beta-acyl-3 beta-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex.lld:pubmed
pubmed-article:8176704pubmed:affiliationDepartment of Chemistry, Wake Forest University, Winston-Salem, North Carolina 27109.lld:pubmed
pubmed-article:8176704pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8176704pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8176704pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:8176704lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8176704lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8176704lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8176704lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8176704lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8176704lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8176704lld:pubmed